These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 15912967)

  • 1. CC-10004 .
    Khobzaoui M; Gutke HJ; Burnet M
    Curr Opin Investig Drugs; 2005 May; 6(5):518-25. PubMed ID: 15912967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CC-1088 Celgene.
    Dredge K
    Curr Opin Investig Drugs; 2005 May; 6(5):513-7. PubMed ID: 15912966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AWD-12-281 (inhaled) (elbion/GlaxoSmithKline).
    Gutke HJ; Guse JH; Khobzaoui M; Renukappa-Gutke T; Burnet M
    Curr Opin Investig Drugs; 2005 Nov; 6(11):1149-58. PubMed ID: 16312137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective phosphodiesterase 4 inhibitors in the treatment of allergy and inflammation.
    Smith VB; Spina D
    Curr Opin Investig Drugs; 2005 Nov; 6(11):1136-41. PubMed ID: 16312135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agents against cytokine synthesis or receptors.
    Yamagata T; Ichinose M
    Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiesterase inhibitors in airways disease.
    Fan Chung K
    Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic benefit of PDE4 inhibitors in inflammatory diseases.
    Dastidar SG; Rajagopal D; Ray A
    Curr Opin Investig Drugs; 2007 May; 8(5):364-72. PubMed ID: 17520865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phosphosdiesterase 4 inhibitors in the treatment of pulmonary diseases].
    Xia XD; Dai YR; Xu ZJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jan; 27(1):57-9. PubMed ID: 14989829
    [No Abstract]   [Full Text] [Related]  

  • 9. The potential role of roflumilast: the new phosphodiesterase-4 inhibitor.
    Karish SB; Gagnon JM
    Ann Pharmacother; 2006 Jun; 40(6):1096-104. PubMed ID: 16735669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetomilast.
    O'Mahony S
    IDrugs; 2005 Jun; 8(6):502-7. PubMed ID: 15906198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel phosphodiesterase 4 inhibitor, CI-1044, inhibits LPS-induced TNF-alpha production in whole blood from COPD patients.
    Ouagued M; Martin-Chouly CA; Brinchault G; Leportier-Comoy C; Depincé A; Bertrand C; Lagente V; Belleguic C; Pruniaux MP
    Pulm Pharmacol Ther; 2005; 18(1):49-54. PubMed ID: 15607127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Selective phosphodiesterase 4 inhibition. Controlling inflammation--also in patients with COPD].
    MMW Fortschr Med; 2004 Apr; 146(18):59. PubMed ID: 15366479
    [No Abstract]   [Full Text] [Related]  

  • 13. Phosphodiesterase-4: selective and dual-specificity inhibitors for the therapy of chronic obstructive pulmonary disease.
    Giembycz MA
    Proc Am Thorac Soc; 2005; 2(4):326-33; discussion 340-1. PubMed ID: 16267357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic obstructive pulmonary disease, inflammation and PDE4 inhibitors.
    Halpin DM
    Br J Hosp Med (Lond); 2006 Jul; 67(7):370-4. PubMed ID: 16884152
    [No Abstract]   [Full Text] [Related]  

  • 15. Roflumilast for the treatment of chronic obstructive pulmonary disease.
    Antoniu SA
    Curr Opin Investig Drugs; 2006 May; 7(5):412-7. PubMed ID: 16729716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inflammatory lung and systemic disease].
    Med Monatsschr Pharm; 2005 Jul; 28(7):254-5. PubMed ID: 16038131
    [No Abstract]   [Full Text] [Related]  

  • 17. Phosphodiesterase 4 inhibitors: antiinflammatory therapy for chronic obstructive pulmonary disease at last?
    Kerstjens HA; Timens W
    Am J Respir Crit Care Med; 2003 Oct; 168(8):914-5. PubMed ID: 14555456
    [No Abstract]   [Full Text] [Related]  

  • 18. The potential of PDE4 inhibitors in asthma or COPD.
    Spina D
    Curr Opin Investig Drugs; 2000 Oct; 1(2):204-13. PubMed ID: 11249575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are phosphodiesterase 4 inhibitors just more theophylline?
    Boswell-Smith V; Cazzola M; Page CP
    J Allergy Clin Immunol; 2006 Jun; 117(6):1237-43. PubMed ID: 16750981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, biological evaluation and molecular modelling studies on benzothiadiazine derivatives as PDE4 selective inhibitors.
    Tait A; Luppi A; Hatzelmann A; Fossa P; Mosti L
    Bioorg Med Chem; 2005 Feb; 13(4):1393-402. PubMed ID: 15670947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.